Bobak R. Azamian - President/CEO and Board Chair, Director at Tarsus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President/CEO and Board Chair, Director
Issuer Symbol
TARS on Nasdaq
All Insider Reports
All Insider Reports

Bobak R. Azamian - trading volume in the past year for Tarsus Pharmaceuticals, Inc.

Holdings reported by Bobak R. Azamian for Tarsus Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 863,991 $64,635,166 $74.81 04 Dec 2025 By the Bobak Azamian Living Trust established April 16, 2018
Stock Option (right to buy) 90,736 $997,189 $10.99 05 Mar 2025 Direct Common Stock
Restricted Stock Units 69,364 $894,102 $12.89 15 Mar 2025 Direct Common Stock
Common Stock 1,750 $130,917 $74.81 04 Dec 2025 Direct

Transactions reported by Bobak R. Azamian for Tarsus Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.